Best Small Cell Lung Cancer Treatment Podcasts (2025)

1
Focus on Small Cell Lung Cancer Treatment in Kentucky 27:01

Play Pause

7h ago27:01

27:01

With a focus on improving access and managing toxicity, this episode covers how new therapies are transforming the landscape for small cell lung cancer patients across the state. Host Dr. Shreyas Kalantri, Hematology and Oncology Chief Fellow at University of Louisville, speaks with experts Dr. Goetz Kloecker and Dr. Firas Badin to discuss groundbr…

1
Lungcast: Current Perspectives on Treatment of Small Cell Lung Cancer with Jacob Sands, MD 36:20

12d ago36:20

36:20

While major advances in screening, targeted treatment and immunotherapy have transformed outcomes for non-small cell lung cancer, progress against small cell lung cancer (SCLC) has lagged behind. In this episode, Jacob Sands, MD, of Dana-Farber Cancer Institute and Harvard Medical School joins us to share insights into the present state of SCLC tre…

1
Talk of Hope | S2, Ep2: The Strictly Special 50:53

6h ago50:53

50:53

In our latest Talk of Hope Podcast, Tina and Karen share their stories of resilience - living with lung cancer and lung disease, finding joy in the darkest of times, and how it led them to the Strictly Ballroom dancefloor.

1
When You’re Handed Lemons, Make Lemonade! 33:53

5d ago33:53

33:53

From Lung Cancer Patient to Full Time Advocate HOST: Hildy Grossman, CO-HOST: Jordan Rich GUEST: Dusty Donaldson, Lung Cancer Patient Advocate, LiveLung Founder At fifty-one, Dusty’s life was a whirlwind. A mother of three, she was also juggling a full-time career and graduate school when a lung cancer diagnosis stopped everything in its tracks. He…

1
Talk of Hope | S2, Ep1: Tour de 4 [Mel Erwin] 57:34

7d ago57:34

57:34

Talk of Hope returns for season two, and by some weird coincidence, we’re joined by our first guest of season one – the wonderful Mel Erwin as she gets ready to embark on the Tour de 4 challenge this Sunday. Support her here: https://www.gofundme.com/f/lung-cancer-research-for-longer-lovelier-lives

1
Transforming Lung Cancer Care in Kentucky 35:04

11d ago35:04

35:04

In the latest episode of KYSCO Oncology Voices, host Dr. Shreyas Kalantri, Hematology and Oncology Chief Fellow at University of Louisville, shares updates on recent advances in non-small cell lung cancer (NSCLC) with renowned experts Dr. Goetz Kloecker and Dr. Firas Badin. They cover landmark trials such as CheckMate 816 (neoadjuvant immunotherapy…

1
S2 Ep48: Breast Cancer Tumor Board: Targeting TROP2 – Innovations in Triple-Negative Breast Cancer Treatment 32:01

12d ago32:01

32:01

Thanks for your interest in this podcast. Please read this important program information before listening. Episode Description In this podcast, experts Joyce O’Shaughnessy, MD; Hope S. Rugo, MD; and Matthew P. Goetz, MD, discuss innovations in targeting TROP2 in triple-negative breast cancer treatment. Learning Objectives Upon successful completion…

1
WHEN YOU HIT A WALL Let Music Change Your Path 36:18

20d ago36:18

36:18

HOST: Hildy Grossman, CO-HOST: Jordan Rich GUEST: Jacy Dawn Valeras, Award-winning Television Host, Producer, Podcaster and Music Business Executive Hildy welcomes Jacy Dawn Valeras—television host, producer, music business executive, and podcaster with over 25 years of experience in the industry. Jacy shares her life-long dream of becoming a count…

1
S2 Ep47: Breast Cancer Tumor Board®: Advancing Care in Metastatic Breast Cancer—The Evolving Role of Antibody-Drug Conjugates 31:00

1M ago31:00

31:00

Thanks for your interest in this podcast. Please read this important program information before listening. Episode Description In this podcast, experts Hope S. Rugo, MD; and Joyce O’Shaughnessy, MD, discuss pivotal trials of antibody-drug conjugates in HR+/HER2- and triple-negative subtypes of metastatic breast cancer. Learning Objectives Upon succ…

1
S2 Ep46: Medical Crossfire®: The Precision Path for HER2 and TROP2-Targeted Treatments in Non–Small Cell Lung Cancer 34:53

1M ago34:53

34:53

Thanks for your interest in this podcast. Please read this important program information before listening. Episode Description In this podcast, experts Benjamin P. Levy, MD; Ticiana Leal, MD; Aaron Lisberg, MD; and Christine M. Lovly, MD, PhD, FASCO, discuss current and emerging treatment strategies targeting HER2 and TROP2 in patients with advance…

1
S2 Ep45: Medical Crossfire®: Precision Medicine in Glioma Treatment — Integration of Molecular Profiling to Inform Targeted Therapies 30:53

1M ago30:53

30:53

Thanks for your interest in this podcast. Please read this important program information before listening. Episode Description In this podcast, experts Vinay Puduvalli, MD; Manmeet Ahluwalia, MD, MBA; Stephen Bagley, MD, MSCE; and Angela Waanders, MD, MPH, MS; discuss advancements in targeted therapies to treat adult and pediatric low- and high-gra…

1
S2 Ep36: Medical Crossfire: Harnessing the Power of Modern Therapies in Newly Diagnosed Multiple Myeloma 35:33

1M ago35:33

35:33

Thanks for your interest in this podcast. Please read this important program information before listening. Episode Description In this podcast, experts Mohamad Mohty, MD, PhD and Surbhi Sidana, MD discuss recent advances in treating and managing newly diagnosed multiple myeloma (NDMM). Learning Objectives Upon successful completion of this activity…

1
S2 Ep37: Evolving Treatment Strategies in Pancreatic Cancer: Current Standards, Emerging Targets, and the Role of Molecular Testing 32:37

2M ago32:37

32:37

Thanks for your interest in this podcast. Please read this important program information before listening. Episode Description In this podcast, experts Eileen O’Reilly, MD, and Brian Wolpin, MD, MPH, discuss current principles for molecular testing and emerging targeted therapy approaches for patients with metastatic pancreatic ductal adenocarcinom…

1
S2 Ep35: Cases and Conversations™: Sorting Through the Expanding Treatment Options for Patients with Relapsed/Refractory Multiple Myeloma 28:30

1M ago28:30

28:30

Thanks for your interest in this podcast. Please read this important program information before listening. Episode Description In this podcast, experts Mohamad Mohty, MD, PhD and Surbhi Sidana, MD discuss recent advances in treatment options for relapsed/refractory multiple myeloma (R/R MM). Learning Objectives Upon successful completion of this ac…

1
S2 Ep42: Medical Crossfire®: Expert Perspectives on c-MET and MET Targeting in NSCLC—Unveiling the Complexities of MET Dysregulation 48:08

1M ago48:08

48:08

Thanks for your interest in this podcast. Please read this important program information before listening. Episode Description In this podcast, experts Alex A. Adjei, MD, PhD, FACP; Sandip Patel, MD, FASCO; and Jeremy Segal, MD, PhD, discuss the emerging data and clinical strategies for targeting c-MET overexpression and MET genomic alterations in …

1
S2 Ep43: GI Tumor Board—Applying Recent Advances in Biomarker Testing and Treatment in Metastatic Colorectal Cancer 31:30

1M ago31:30

31:30

Thanks for your interest in this podcast. Please read this important program information before listening. Episode Description In this podcast, experts Drs Stacey Cohen, Aparna Parikh, Kanwal Raghav, and John Strickler discuss advancements in targeted therapies to treat adult metastatic colorectal cancer. Learning Objectives Upon successful complet…

1
S2 Ep41: Cases & Conversations™: Transforming AML Care – Precision Strategies, Evolving Therapies, and Clinical Insights 17:15

1M ago17:15

17:15

Thanks for your interest in this podcast. Please read this important program information before listening. Episode Description In this podcast, experts Gail J. Roboz, MD; Hagop Kantarjian, MD; Catherine Lai, MD, MPH; and Amer Zeidan, MBBS, MHS; discuss current best practices and emerging strategies in acute myeloid leukemia (AML) management. Learni…

1
S2 Ep44: PER Tumor Board®: Applying Recent Advances to Transform the Treatment Paradigm in SCLC – Expert Perspectives on New Approvals and Emerging Strategies 21:10

1M ago21:10

21:10

Thanks for your interest in this podcast. Please read this important program information before listening. Episode Description In this podcast, experts Jonathan W. Goldman, MD; Percy Lee, MD, FASTRO; Erminia Massarelli, MD, PhD, MS; and Misty D. Shields, MD, PhD; discuss recent advances and emerging approaches—including immunotherapy, DLL3-targeted…

1
S2 Ep40: Tumor Board: Expert Insights on Managing Classical EGFR Mutations, EGFR Exon 20 Insertions, and Atypical EGFR Mutations in Metastatic NSCLC 29:28

1M ago29:28

29:28

Thanks for your interest in this podcast. Please read this important program information before listening. Episode Description In this podcast, experts Balazs Halmos, MD, MS; Enriqueta Felip, MD, PhD; and Julia Rotow, MD; discuss the latest evidence in managing EGFR-mutated non–small cell lung cancer (NSCLC), with a focus on personalized treatment …

1
S2 Ep38: Show Me the Data™ New Frontiers in the Treatment of Ovarian Cancer 32:37

1M ago32:37

32:37

Thank you for your interest in this podcast. Please read this important program information before listening. Episode Description In this podcast, experts Rachel N. Grisham, MD; Oladapo O. Yeku, MD, PhD, FACP; and Ramez N. Eskander, MD, explore new frontiers in the treatment of ovarian cancer, including advances in biomarker-driven decision-making,…

1
S2 Ep39: Medical Crossfire: Improving Patient Outcomes in Myeloproliferative Neoplasms With Novel Therapeutic Approaches 21:36

1M ago21:36

21:36

Thanks for your interest in this podcast. Please read this important program information before listening. Episode Description In this podcast, experts Gabriela Hobbs, MD; John O. Mascarenhas, MD; and Naveen Pemmaraju, MD; discuss recent advances in therapies for myelofibrosis (MF), polycythemia vera (PV), and essential thrombocytopenia (ET). Learn…

1
Talk of Hope | S1, Ep13: From stage 1 to 3b and back again [Jane Holmes] 1:04:55

2M ago1:04:55

1:04:55

Jane Holmes was 43, fit, and feeling fine when she was diagnosed with inoperable lung cancer. That was 11 years ago. In our latest Talk of Hope podcast, Jane shares how her determination, second opinions, and a surgeon willing to say "yes" helped her beat the odds – and change minds in the process.

1
Lungcast: The Lung-Gut Axis - Where Nutrition & Lung Health Intersect with Neal Barnard, MD 23:05

2M ago23:05

23:05

Microbiome is a mysterious medical frontier with more questions than answers. In this episode, nutrition expert Neal Barnard, MD, of George Washington University explores the connection between diet, gut microbiome and lung health. While fiber and plant-based diets have been shown to shape a healthier microbiome, this conversation sheds light on th…

1
PROGRESS BRINGS HOPE FOR SMALL CELL LUNG CANCER 37:51

2M ago37:51

37:51

Voicing New Reasons for Optimism HOST: Hildy Grossman, CO-HOST: Jordan Rich GUEST: Maida Mangiameli, Dusty Donaldson, Misty Shields, MD, Ph.D., and Ann Steagall Small cell lung cancer (SCLC) is a highly aggressive form of lung cancer with a 5-year survival rate of just 7%, a disheartening statistic. Despite this, survivors, researchers, and the med…

1
Talk of Hope | S1, Ep12: The Cancer Co-Pilot [Sarah Richards] 51:34

2M ago51:34

51:34

When lung cancer strikes, it doesn’t just hit the person diagnosed. It affects everyone close to them, too. In our latest Talk of Hope podcast, we chat to Sarah Richards about what it’s like to be a ‘cancer copilot’.

1
Key Breast Cancer Updates from Recent SERENA-6 and ASCENT-04 Trials 52:04

2M ago52:04

52:04

Are you up-to-date with the latest breast cancer advances? In the latest episode of KYSCO Oncology Voices, host Dr. Matthew Kurian discusses key breast cancer updates from ASCO 2025 with guest experts Dr. Brian Dong and Dr. Ruta Arays. They explore trial results, including SERENA-6 and ASCENT-04, and their potential implications for treatment decis…

1
Talk of Hope | S1, Ep11: Liquid Biopsy explained! 56:33

2M ago56:33

56:33

Back at the end of May, it was announced that NHS England are to roll out a pioneering blood test that could transform lung cancer treatment. In this episode, we chat through this latest new development with Professor Alastair Greystoke and guest co-host Yvonne Diaz and what it could mean for people with lung cancer.…

1
S2 Ep34: PER Podcast™: Best Strategies for Approaching the Diagnosis of Amyotrophic Lateral Sclerosis (ALS) 26:04

3M ago26:04

26:04

Episode Description In this podcast, ALS expert Terry Heiman-Patterson, MD, discusses best practices for ALS diagnosis and use of targeted therapy. Learning Objectives Upon successful completion of this activity, you should be better prepared to: Apply recommended diagnostic criteria and strategies to make an early, accurate diagnosis of ALS Discus…

1
S2 Ep33: PER Podcast™: Maximizing the Multidisciplinary Care Outcomes of Patients with Amyotrophic Lateral Sclerosis (ALS) 24:46

3M ago24:46

24:46

Episode Description In this podcast, ALS expert clinician-researcher Richard Bedlack MD, PhD, discusses targeted therapy for ALS and the role of individualized, multidisciplinary care to optimize patient outcomes. Learning Objectives Upon successful completion of this activity, you should be better prepared to: Discuss the mechanisms of action, eff…

1
S2 Ep32: Breaking Barriers in HER2-Mutant NSCLC: Exploring the Promise of Next-Generation TKIs 26:11

3M ago26:11

26:11

Episode Description In this episode of the PER® podcast, we explore the evolving landscape of HER2-mutant non–small cell lung cancer (NSCLC)—a rare and historically difficult-to-treat subset of lung cancer. Join Millie Das, MD, from Stanford/VA Palo Alto; and Eric Kumar Singhi, MD, from The University of Texas MD Anderson Cancer Center; as they del…

1
Lung Cancer Biomarkers: A New Frontier in Early Detection with Lindsey Cotton, D.O.Med, DHSc, MS 37:34

3M ago37:34

37:34

This episode featuring clinician-scientist and expert in liquid biopsy development, Dr. Lindsey Cotton, who explores the evolving science of lung cancer biomarkers and their role in early detection. Listen in to learn more about the current landscape, benefits and challenges of both organ-specific and multi-cancer tests. The highly informative disc…

1
Talk of Hope | S1, Ep10: Clinical Trials Explained [Ann Doran] 1:00:19

3M ago1:00:19

1:00:19

Clinical trials are crucial for the advancement of treatment, so we’ve been chatting to helpline nurse, Ann, about all things clinical trials. Listen now on our Talk of Hope podcast.

1
ALL IN THE FAMILY Is Lung Cancer Inherited? 37:10

3M ago37:10

37:10

HOST: Hildy Grossman, CO-HOST: Jordan Rich GUESTS: Jaclyn LoPiccolo, MD, Ph.D., Pasi Janne, MD, Ph.D., Dana Farber Cancer Institute and Jill Feldman, EGFR Resisters Hildy opens with a powerful anecdote about an early Upstage Lung Cancer Board member whose mother, grandmother, and aunt all had lung cancer. She endured months of allergy and antibioti…

1
S2 Ep31: Show Me Your Care Plan!™ Insights for Oncology Nurses on Comprehensive SCLC Treatment and Care Strategies 1:04:32

3M ago1:04:32

1:04:32

Episode Description In this podcast, experts Andy Guinigundo, MSN, RN, CNP, ANP-BC, FAPO, and Fred Hirsch, MD, PhD, review the evolving treatment landscape for limited-stage small-cell lung cancer (LS-SCLC) and extensive-stage (ES) SCLC, including a discussion of the latest strategies for managing common and severe treatment-related adverse events.…

1
Talk of Hope | S1, Ep9: Marathons and small cell lung cancer [Sean Kelly] 1:13:32

4M ago1:13:32

1:13:32

Today’s guest, Sean Kelly, has endured a very difficult few months since his small cell lung cancer diagnosis in February. He has also had to give up running which was a massive part of his life and a big passion. It’s all been a huge adjustment for him and he’s here today to tell us all about it.

1
Prostate Cancer Care in Kentucky 37:51

4M ago37:51

37:51

Kentucky is working to reduce disparities and improve early cancer detection. In the inaugural episode of the Kentucky Society of Clinical Oncology (KYSCO) Podcast, host Dr. Matt Kurian talks with experts Mollie Beck, Oncology Pharmacist, and Jordan Brady, Coordinator of Clinical Genetics, about everything from local statistics to genetic screening…

1
S2 Ep30: Show Me Your Care Plan!™ Insights for Oncology Nurses: Integrating Recent Developments to Improve Outcomes for Patients with Platinum-Resistant Ovarian Cancer 1:26:00

4M ago1:26:00

1:26:00

Episode Description This PER® Show Me Your Care Plan!™ featured podcast brings together two medical oncologists and an oncology nurse to discuss the latest advances in the management of platinum-resistant ovarian cancer (PROC). The expert panel reviews current and emerging therapies, with a special focus on the management of adverse events associat…

1
Evaluating Dato-DXd for EGFR-Mutated Advanced NSCLC: Data from a Pooled Analysis

4M ago

—

Host: Jacob Sands, MD Guest: Elaine Shum, MD Guest: Estelamari Rodriguez, MD, MPH There was a recent pooled analysis of the TROPION-Lung01 and TROPION-Lung05 studies, which focused on the efficacy and safety of datopotamab deruxtecan (Dato-DXd) in patients with previously treated EGFR-mutated advanced non-small cell lung cancer (NSCLC). According t…

1
Going for GOLD: Updated COPD Guidelines with Gerard Criner, MD 28:31

3M ago28:31

28:31

Earlier this year, the Global Initiative for Obstructive Lung Disease (GOLD) guidelines were updated to include a new emphasis on cardiovascular disease and pulmonary hypertension in COPD, among much more. Rejoining us for an episode exploring these revisions is Gerard Criner, MD, of Temple University, a foremost COPD expert who serves on the GOLD …

1
Lungcast: ATS 2025, with Harold P. Wimmer and Francesca Polverino, MD, PhD 8:24

4M ago8:24

8:24

This special episode features 2 interviews on-site at the 2025 American Thoracic Society (ATS) International Conference in San Francisco: Harold P. Wimmer, CEO of the American Lung Association, and Francesca Polverino, MD, PhD, a professor at Baylor College of Medicine and spokesperson for the ALA. View the latest conference coverage from this meet…

1
Talk of Hope | S1, Ep8: Staying hopeful after progression [Jules Fielder] 48:18

4M ago48:18

48:18

Jules is living with stage 4 EGFR+ lung cancer, which had originally spread to her pelvis and spine. At the beginning of the year, Jules received the news that everyone with lung cancer fears. Her cancer had progressed. But in true Jules style, she’s still hopeful – got another holiday lined up – and here to talk as openly as ever about a very diff…

1
2025 State of the Air: Dangers of the Air We Breathe with George Thurston, ScD 31:31

4M ago31:31

31:31

An internationally recognized leader in air quality, epidemiology and exposure assessment, George Thurston, ScD, of New York University headlines this important episode analyzing the Lung Association’s 2025 “State of the Air” report. With nearly half of the people living in the U.S. breathing unhealthy amounts of air pollution, Thurston delves into…

1
Living with ALK+: Diagnosis, Treatment, & Hope 33:55

4M ago33:55

33:55

A Biomarker Dialogue Between Patient and Scientist HOST: Hildy Grossman, CO-HOST: Jordan Rich GUEST: Marc Muskavitch, PhD, ALK+ & Zachary Rogers, PhD, Research Fellow, Koch Institute at MIT This episode features a powerful conversation between two scientists, one now navigating life as a Stage 4 ALK+ lung cancer patient. Most lung cancer patients o…

1
Talk of Hope | S1, Ep7: Lung cancer and travel insurance with Insurancewith [Fiona Macrae] 54:38

5M ago54:38

54:38

In this week’s Talk of Hope podcast, we cover the always hot topic of travel insurance (very appropriate after the mini heatwave gave us serious holiday vibes last week!) Joining us is Fiona Macrae, founder of Insurancewith. Fiona truly understands how difficult it can be for people withcancer to get insurance, especially those with a stage 4 diagn…

1
Talk of Hope | S1, Bonus Ep3: Post London Marathon 2025 special [Joe Gill, Khang Lê] 36:36

5M ago36:36

36:36

Less than a week ago, around 56,000 people took on the London Marathon in sweltering conditions. On this bonus episode of our Talk of Hope podcast, we caught up with two of our runners, Joe Gill and Khang Le to see how they got on.

1
Lung Cancer Screening: A Decade of Lessons Learned with Mary Pasquinelli, DNP 35:36

5M ago35:36

35:36

It has been more than a decade since lung cancer screening guidelines via low-dose CT, based on the USPSTF’s B recommendations, have been put into place. To discuss the guidelines’ ambitions and obstacles, we are joined by the University of Illinois Health System’s Mary Pasquinelli, DNP, who specializes in lung cancer, lung cancer screening and pul…

1
Talk of Hope | S1, Bonus Ep2: London Marathon 2025 special [Joe Gill, Khang Lê and Ruth Chappell] 53:37

5M ago53:37

53:37

This London Marathon week we have a special bonus episode... We chat to two of this year’s runners, Joe Gill and Khang Lê who are running those iconic 26.2 miles (don’t forget the .2) in memory of their mums, as well as London Marathon veteran Ruth Chappell, who has run the race not once but twice!

1
Talk of Hope | S1, Ep6: The joy of volunteering [Diane Fraser] 49:25

5M ago49:25

49:25

Diane Fraser is a volunteering virtuoso! From being part of the team in head office to joining us at fundraising events, there’s nothing Diane wouldn’t do to help our charity – including tattooing children at Spooky Welly Walk! Listen to Diane share her experience of volunteering and why she chose to give her time to us.…

1
Talk of Hope | S1, Ep5: Cancer may take my life, but it’s also given it back to me [Paul Moors] 55:37

6M ago55:37

55:37

Listen to our latest episode with Paul, where we talk about his life with advanced lung cancer and brain mets, the worst bit of immunotherapy and rocking out to ACDC during targeted brain radiotherapy.

1
Talk of Hope | S1, Bonus Ep1: [Lucy Woollard & Charlotte Sargent] 25:29

6M ago25:29

25:29

We're excited to share a bonus episode of our Talk of Hope podcast, featuring mother and daughter duo – Lucy Woollard and Charlotte Sargent. Lucy has been involved with our charity for many years after her diagnosis back in 2009. Charlotte was only two years old at the time and Lucy faced the very real prospect of not seeing her daughter grow up. F…